91 related articles for article (PubMed ID: 17032900)
61. Statistically derived predictive models. Caveat emptor.
Iezzoni LI
J Gen Intern Med; 1999 Jun; 14(6):388-9. PubMed ID: 10354262
[No Abstract] [Full Text] [Related]
62. Commentary: Fifty years of the multistage model: remarks on a landmark paper.
Moolgavkar SH
Int J Epidemiol; 2004 Dec; 33(6):1182-3. PubMed ID: 15319398
[No Abstract] [Full Text] [Related]
63. Crude rates of outcome.
Julious SA; Mullee MA
Br J Surg; 2000 Jan; 87(1):8-9. PubMed ID: 10606905
[No Abstract] [Full Text] [Related]
64. [Positive Impact of ASS on Cancer Incidence and Mortality].
Norman K; Schulzke JD
Z Gastroenterol; 2011 Apr; 49(4):532-3. PubMed ID: 21476184
[No Abstract] [Full Text] [Related]
65. Predictors for mortality.
Mitchell B
Arch Dis Child Fetal Neonatal Ed; 1995 Sep; 73(2):F123. PubMed ID: 7583606
[No Abstract] [Full Text] [Related]
66. Screening libraries--the seven ages.
Crossley R
IDrugs; 2001 May; 4(5):481-2. PubMed ID: 16012879
[No Abstract] [Full Text] [Related]
67. Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.
Mahnken JD; Chan W; Freeman DH; Freeman JL
Stat Methods Med Res; 2008 Dec; 17(6):643-63. PubMed ID: 18445697
[TBL] [Abstract][Full Text] [Related]
68. A stochastic model for predicting the mortality of breast cancer.
Lee S; Zelen M
J Natl Cancer Inst Monogr; 2006; (36):79-86. PubMed ID: 17032897
[TBL] [Abstract][Full Text] [Related]
69. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
[TBL] [Abstract][Full Text] [Related]
70. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
[TBL] [Abstract][Full Text] [Related]
71. The MISCAN-Fadia continuous tumor growth model for breast cancer.
Tan SY; van Oortmarssen GJ; de Koning HJ; Boer R; Habbema JD
J Natl Cancer Inst Monogr; 2006; (36):56-65. PubMed ID: 17032895
[TBL] [Abstract][Full Text] [Related]
72. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis.
Cronin KA; Feuer EJ; Clarke LD; Plevritis SK
J Natl Cancer Inst Monogr; 2006; (36):112-21. PubMed ID: 17032901
[TBL] [Abstract][Full Text] [Related]
73. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative?
Habbema JD; Tan SY; Cronin KA
J Natl Cancer Inst Monogr; 2006; (36):105-11. PubMed ID: 17032900
[TBL] [Abstract][Full Text] [Related]
74. A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.
Clarke LD; Plevritis SK; Boer R; Cronin KA; Feuer EJ
J Natl Cancer Inst Monogr; 2006; (36):96-105. PubMed ID: 17032899
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
